D uring rolling, sliding and patient positioning, the pilot balloon and inflation line of a tracheal tube can be damaged leading to deflation of the cuff. Tube exchange is essential in this circumstance, but in cases where intubation was difficult, or where the patient is unstable, a brief holding measure may be desired while further support is called and preparations are made for tube exchange.
The cuff can be re-inflated using simple equipment found in the intensive care unit. If the pilot balloon is amputated, an 18 or 20 gauge IV cannula can be fully advanced into the damaged inflation line. The needle is then removed and a 3-way tap attached. A syringe of air is used to re-inflate the cuff and the 3-way tap used as a valve. Pressure in the cuff can be monitored by attaching a manometer to the 3-way tap (Figure 1) .
A completely severed pilot balloon can be easily detected on initial assessment of the tracheal tube, but the source of a leaking cuff is often much more elusive. When a cuff leak is detected in a previously functioning tracheal tube, it may be due to mal-position of the tube, or compromise to the cuff or inflation system. Tube depth can be checked against documentation of the original fixation position, and tube placement can be confirmed by direct laryngoscopy. If a trial of air top-up temporarily improves the picture, an incompetent cuff or inflation system is the likely cause and close inspection of the inflation line and pilot balloon may reveal damage.
In previous literature, Sills has described a technique for cuff re-inflation by introducing a hypodermic needle into the inflation line and injecting air. 1 Watson has described a cure for a leaking 1-way valve by purposefully cutting away the pilot balloon and re-inflating the cuff using a 22 gauge cannula. 2 It must be remembered that repairing equipment is not a permanent solution to a leaking cuff, and is only recommended as an emergency measure while preparations for a safe tube exchange are being made.
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No external funding received. No conflicts of interest. I read with interest the audit of outcomes of therapeutic hypothermia post-cardiac arrest by Nichani et al. 1 They acknowledge that the evidence of when to induce hypothermia is 'debatable' and that a delay may be beneficial; 'whether a quicker time to cooling alters neurological outcome is unclear.' While I agree that it is debatable, initial animal studies showed that earlier was better. 2 In contrast, a registry-based case series documented that time to initiation of cooling was not associated with improved neurological outcome post discharge. 3 In another case series, the time to coldest temperature (TCT) was an independent predictor of good neurological outcome. 4 It is reasonable to conclude that the human data supporting earlier cooling is inconclusive and that the optimal cooling strategy remains unknown. 5 Haugk et al 6 cast doubt on early cooling but the evidence is weak, with the authors themselves admitting that their study was limited by its retrospective, observational, descriptive, single-centre nature and that: 'if faster cooling is detrimental or patients with more severe neurological damage show a faster cooling rate, has to be further evaluated.' 6 I would hypothesise that the times to the target cooling range achieved in the HACA trail 7 and in this audit 1 were based more on logistical constraints rather than deliberate strategies.
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Nichani et al 1 reported the median time from return of spontaneous circulation (ROSC) to target temperature was 425 minutes, which, compared to the landmark study by Bernard et al 8 (120 minutes) is rather long, but likely consistent with experience in the rest of the NHS. These timings were similar to the HACA group, 7 480 minutes to achieve target, and this remains the best quality trial that exists on the subject. P lumb correctly points out that there is as yet no clear evidence of benefit for the practice of early cooling to target temperature, nor indeed, evidence for delaying this process.
In a prospective randomised trial in patients with out-ofhospital (OOH) VF arrest, 1 Bernard et al showed that there was no difference in functional status at hospital discharge between patients treated with earlier prehospital cooling and those for whom cooling was commenced in hospital. One of the limitations of this study was that there were relatively short transport times to hospital, which potentially negated the beneficial effects of pre-hospital cooling.
The same investigators confirmed the overall lack of benefit in pre-hospital cooling in another randomised trial of patients with non-VF cardiac arrest. 2 This study also has similar limitations with respect to short transfer times negating any potential benefits, but also was significantly underpowered for the primary outcome of favourable status at hospital discharge. Both of these studies are probably not applicable to clinical practice in which long transfers across a wide geographical area may be undertaken.
Our study documented current practice in cooling postcardiac arrest patients within a specific geographical area of the UK and was not designed to assess the benefits of different cooling strategies on outcome. We agree with Plumb in that further research with adequately powered, randomised trials is necessary to determine the optimal time to cooling and the effects of earlier cooling in the pre-hospital setting including cooling during cardio-pulmonary resuscitation.
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It is worth analysing the study protocols of these two landmarks studies. Bernard' s group aimed to achieve 33°C within 120 minutes and to cool for 12 hours, with re-warming commencing at 18 hours. In the hypothermia group, paramedics began measures in the field to initiate hypothermia by removing the patient' s clothing and applying cold packs.
The HACA group 7 targeted 32-34°C for 24 hours, which is more in line with current UK practice. They aimed to reach the target within four hours. Passive rewarming occurred over eight hours.
I currently work in the South island of New Zealand in an intensive care unit that accepts transfers from a wide geographical area; we offer the only interventional cardiology service for the southern South Island. By default, a helicopter ride in the South Island, even in the summer, means that arriving temperature on our unit is very often already into the target range of 32-34°C without active cooling measures. By contrast in the Bernard et al study 8 on admission to the emergency department, the hypothermia group temperature was 35.0°C ± 1.28°C and the normothermia group was 35.3°C ± 0.90°C, likely representing short road ambulance transfers.
Ongoing research is needed to determine the optimum timing for the initiation of therapeutic hypothermia. In the meantime our unit will not change our current practice but any new evidence that suggested that delayed cooling is in fact beneficial would certainly affect how we package and transfer this patient group.
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